MK-7145
- Generic Name
- MK-7145
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C26H30N2O6
- CAS Number
- 1255204-84-2
- Unique Ingredient Identifier
- M371870BYL
- Background
MK-7145 has been used in trials studying the treatment of Hypertension and Renal Insufficiency.
- Associated Conditions
- -
- Associated Therapies
- -
The Pharmacokinetics of MK-7145 Following Single Dose Administration in Participants With Moderate Renal Insufficiency (MK-7145-018)
- First Posted Date
- 2013-04-15
- Last Posted Date
- 2013-09-24
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Registration Number
- NCT01832103
A Study of MK-7145 in Participants With Renal Insufficiency (Part I) and Heart Failure With Renal Insufficiency (Part II) (MK-7145-011)
Phase 1
Terminated
- Conditions
- Interventions
- First Posted Date
- 2012-03-20
- Last Posted Date
- 2018-09-21
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 11
- Registration Number
- NCT01558674
A Study of MK-7145 Compared to Placebo and Hydrochlorothiazide for Lowering Blood Pressure in Male Participants With Hypertension (MK-7145-009)
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-06-10
- Last Posted Date
- 2018-09-21
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 46
- Registration Number
- NCT01370655
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath